Insider · CIK 0001331155
Douglas B Croxall
Files at CRKN (Crown Electrokinetics Corp.). First filing -, latest -.
In brief
Douglas B Croxall files SEC Form 4 as CEO and director at CRKN (Crown Electrokinetics Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Douglas B Croxall has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | CRKN Crown Electrokinetics Corp. | AGrant or award Common Stock | +311,535 | $0.00 | $0 | 311,686 | Apr 29, 2025 |
| Apr 25, 2025 | CRKN Crown Electrokinetics Corp. | AGrant or award Common Stock | +311,535 | $0.00 | $0 | 623,221 | Apr 29, 2025 |
| Oct 27, 2023 | CRKN Crown Electrokinetics Corp. | AGrant or award Restricted Stock Unitsderivative | +1,077,675 | $0.00 | $0 | 1,227,675 | Mar 28, 2024 |
Questions about Douglas B Croxall
Answered from the filings on this page, as of the latest one.
Is Douglas B Croxall buying or selling?
Douglas B Croxall has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Douglas B Croxall's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas B Croxall has 0.
Where does Douglas B Croxall file Form 4?
Douglas B Croxall has filed Form 4 at CRKN (Crown Electrokinetics Corp.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.